The Boston Keratoprosthesis: Comparing Corneal Epithelial Cell Compatibility with Titanium and PMMA

被引:33
|
作者
Ament, Jared D. [1 ,2 ]
Spurr-Michaud, Sandra J. [1 ]
Dohlman, Claes H. [1 ,2 ]
Gipson, Ilene K. [1 ]
机构
[1] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA
关键词
Boston Keratoprosthesis; biomaterials; titanium; corneal cell compatibility; INTRAOCULAR LENSES; RESIDUAL MONOMER; BIOMATERIALS; CYTOTOXICITY; PARTICLES; RESINS;
D O I
10.1097/ICO.0b013e31819670ac
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To determine in vitro whether titanium is superior corneal cell compatibility to standard polymethyl-methacryl ate (PMMA) for the Boston Keratoprosthesis (KPro). Methods: Human corneal-limbal epithelial (HCLE) cells were Cultured 24, 48, 72 96, 120, 144. or 168 hours in culture plates alone (controls) or with PMMA or titanium discs. Experiments were performed in triplicate and repeated (final n = 6). To determine if a Soluble, toxic factor is emitted from materials, concurrent experiments at 48 and 144 hours were performed with discs placed in Transwell Supports, with HCLE cells plated beneath. As an additional test for soluble factors, cells were incubated 24 hours with disc-conditioned media, and number of viable cells per well was quantified at each timepoint by proliferation assay. To determine if delayed cell proliferation was attributable to cell death, HCLE cell death was measured under all conditions and quantified at each timepoint by cytotoxicity assay. The effects of material on HCLE cell proliferation over time was determined by repeated measures ANOVA. P < 0.05 was statistically significant. Results: HCLE cell proliferation was greater in wells with titanium discs compared to PMMA. Differences between the test discs and control non-disc cocultures were statistically significant over time for both cell proliferation (P = 0.001) and death (P = 0.0025). No significant difference Was found using Transwells (P = 0.9836) or disc-conditioned media (P = 0.36). Conclusion: This in vitro HCLE cell model demonstrates significantly increased cell proliferation and decreased cell death with cell/titanium contact compared to cell/PMNA contact. Moreover, differences are unlikely attributable to a soluble factor. Prospective in vivo analysis of the two KPro biomaterials is indicated.
引用
收藏
页码:808 / 811
页数:4
相关论文
共 50 条
  • [21] Importance of nutrition to corneal grafts when used as a carrier of the Boston keratoprosthesis
    Harissi-Dagher, Mona
    Khan, Bilal F.
    Schaumberg, Debra A.
    Dohlman, Claes H.
    CORNEA, 2007, 26 (05) : 564 - 568
  • [22] Corneal graft dellen in a patient implanted with a Boston keratoprosthesis type 1
    Scotto, Riccardo
    Vagge, Aldo
    Traverso, Carlo E.
    INTERNATIONAL OPHTHALMOLOGY, 2017, 37 (01) : 263 - 266
  • [23] Primary Implantation of Type I Boston Keratoprosthesis in Nonautoimmune Corneal Diseases
    Chang, Han-Ying Peggy
    Luo, Zhonghui Katie
    Chodosh, James
    Dohlman, Claes H.
    Colby, Kathryn A.
    CORNEA, 2015, 34 (03) : 264 - 270
  • [24] Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure
    Driver, Todd H.
    Aravena, Carolina
    Duong, Huong N. V.
    Christenbury, Joseph G.
    Yu, Fei
    Basak, Samar K.
    Aldave, Anthony J.
    CORNEA, 2018, 37 (11) : 1400 - 1407
  • [25] The Use of Precut, γ-Irradiated Corneal Lenticules in Boston Type 1 Keratoprosthesis Implantation
    Akpek, Esen K.
    Aldave, Anthony J.
    Aquavella, James V.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (03) : 495 - 498
  • [26] Boston Type 1 Keratoprosthesis for Gelatinous Drop-Like Corneal Dystrophy
    Lekhanont, Kaevalin
    Jongkhajornpong, Passara
    Chuephanich, Pichaya
    Inatomi, Tsutomu
    Kinoshita, Shigeru
    OPTOMETRY AND VISION SCIENCE, 2016, 93 (06) : 640 - 646
  • [27] Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency
    Aravena, Carolina
    Bozkurt, Tahir Kansu
    Yu, Fei
    Aldave, Anthony J.
    CORNEA, 2016, 35 (09) : 1156 - 1164
  • [28] In Situ Corneal Cross-Linking for Recurrent Corneal Melting After Boston Type 1 Keratoprosthesis
    Toth, Gabor
    Bucher, Franziska
    Siebelmann, Sebastian
    Bachmann, Bjoern
    Hermann, Manuel
    Szentmary, Nora
    Nagy, Zoltan Zsolt
    Cursiefen, Claus
    CORNEA, 2016, 35 (06) : 884 - 887
  • [29] In Vitro and In Vivo Assessment of Titanium Surface Modification for Coloring the Backplate of the Boston Keratoprosthesis
    Paschalis, Eleftherios I.
    Chodosh, James
    Spurr-Michaud, Sandra
    Cruzat, Andrea
    Tauber, Allyson
    Behlau, Irmgard
    Gipson, Ilene
    Dohlman, Claes H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (06) : 3863 - 3873
  • [30] Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review
    Shanbhag, Swapna S.
    Saeed, Hajirah N.
    Paschalis, Eleftherios I.
    Chodosh, James
    OCULAR SURFACE, 2018, 16 (03): : 272 - 281